Cancer Gene Therapy
Data on cancer gene therapy described by researchers at Columbia University, Department of Environmental Health Sciences
Published in Clinical Oncology Week, May 14th, 2007
A new study, "Predicting hepatocellular carcinoma by detection of aberrant promoter methylation in serum DNA," is now available. "Most hepatocellular carcinomas (HCC) are diagnosed at an advanced stage. Hypermethylation of CpG islands in promoter regions is now recognized as an important early event in carcinogenesis and detection of methylated DNA has been suggested as a potential biomarker for early detection of cancer," scientists writing in the journal Clinical Cancer Research report.
"There are no studies on epigenetic changes in samples from HCC patients before diagnosis. We explored the possible diagnostic value of aberrant promoter hypermethylation of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Cancer
$1.5 million awarded for palliative care research - Cancer
'Wrapping' Gleevec fights drug-resistant cancer - Cancer
Catching cancer's spread by watching hemoglobin - Cancer
Chinese medicinal compound stops formation of cysts in polycystic kidney disease in lab - Cancer
Linking DNA and histone methylation - Cancer
No increased risk of certain cancers from electromagnetic fields among energy workers - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
